基于药品价值链角度对香港地区药品价格管理机制的研究

发布时间：2018-02-26 23:32

本文关键词： 药品价格管理定价流通补偿　出处：《中国药房》2016年01期 　论文类型：期刊论文

【摘要】：目的:探讨我国香港地区药品价格的管理机制,为大陆地区提供借鉴。方法:从香港地区药品价格管理的每个环节出发,基于整个药品价值链,研究其药品定价、流通和补偿过程中的管理机制。结果与结论:香港地区药品定价方式主要为招标定价法,由医院管理局与药品供应商谈判确定采购价格;在流通方面,以药品支付方作为招标采购主体,对药品进行带"质"招标和带"量"采购,公立医院不加价销售;最后采购价格再经过政府补偿环节最终形成患者实际支付的药品价格。大陆地区可以借鉴其药品招标模式,将医保部门作为招标的主体,弱化医院与药品经销商或生产商之间的联系;扩大政府对公立医疗机构的财政投入,提高药品报销水平。
[Abstract]:Objective: to explore the management mechanism of drug price in Hong Kong, and to provide reference for mainland China. Methods: starting from every link of drug price management in Hong Kong, based on the whole drug value chain, we study the drug pricing in Hong Kong. Management mechanism in the process of circulation and compensation. Results and conclusions: the pricing method for drugs in Hong Kong is mainly the bidding pricing method, which is negotiated by the Hospital Authority with drug suppliers to determine the purchase price. Taking the drug payer as the main body of bidding and purchasing, bidding and purchasing the drugs with "quality" and "quantity", the public hospital does not increase the price of the purchase; In the end, the purchase price will eventually form the drug price actually paid by the patient after the government compensation link. The mainland can draw lessons from its drug bidding model and take the medical insurance department as the main body of the bidding. Weakening the relationship between hospitals and drug dealers or manufacturers, expanding the government's financial investment in public medical institutions, improving the level of drug reimbursement.
【作者单位】：中国药科大学国际医药商学院;
【基金】：国家自然科学基金资助项目(No.71273278)
【分类号】：R95

【参考文献】